At this time, New York Oncology Hematology does not have access to acquire and administer the new COVID prophylaxis shot Evusheld for immunocompromised patients. We await further guidance from NYS and will keep our patients updated.

About Us

New Breast Cancer Research Trial at NYOH

9/01/2016

NYOH is currently enrolling eligible breast cancer patients in a new clinical research trial for Embraca. This Phase III research study is for those with advanced of metastatic breast cancer who also have the inherited BRCA 1 or 2 mutation. 

For more information, please call NYOH 518-489-3612 x1045.

Visit www.newyorkoncology.com/clinical-trials-research/ for a full list of open trials, available at NYOH locations.